On 22 July 2026 Meta updated its Health and Wellness advertising policy. The permitted list now explicitly includes ads for cosmetic products, procedures and surgeries "depicting before and after transformation", provided they are targeted to people aged 18 and over (Meta Transparency Center, 2026). Plenty of clinics read that as a green light and reinstated old creatives. That is an expensive misreading. The platform is only one of two gates a creative has to pass, and in Poland the second gate is far narrower: advertising a business that uses a medical device to deliver its services falls under the Medical Devices Act of 7 April 2022, with fines reaching PLN 2,000,000.
Two gates, not one
A before-and-after creative has to clear two independent checks that have nothing to do with each other. The first is platform policy. The second is national law. Approval by the first is not evidence of compliance with the second, because Meta applies one global standard and knows nothing about the Polish Medical Devices Act.
| Criterion | Gate A: Meta | Gate B: national regulator |
|---|---|---|
| Who reviews | automated systems and a review workforce of over 15,000 people | the President of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products (URPL) |
| When | before the campaign starts, within hours | after publication, potentially years later |
| Sanction | ad rejection, account restriction | financial penalty, removal order, order to publish the decision |
| Reversibility | high, edit the creative and resume | low, the decision is immediately enforceable |
Most clinics optimise for Gate A only, because it is the one that gives instant feedback. Gate B stays silent until a request to produce advertising samples arrives.
Gate A: what Meta allows
The current Health and Wellness policy permits advertising procedures such as dermal fillers, injectable treatments, chemical peels, micro-needling, non-ablative laser treatments and skin rejuvenation, and it permits showing a before-and-after transformation when targeting is set to 18+.
Meta still prohibits, among other things:
- statements of inferiority about physical appearance, meaning language that attacks a person's looks, specific body parts or hygiene,
- shots such as a close-up on a body area with fat being pinched,
- health clickbait: sensational language, extreme claims, or promises of a specific outcome within a set timeframe without qualifiers,
- skin whitening or bleaching products that cause permanent colour change.
This matters, because the typical transformation creative usually breaks the inferiority rule in its primary text rather than the before-and-after rule itself.
Gate B: what the law actually says
Neither the Medical Devices Act nor the Minister of Health regulation of 21 April 2023 imposes a blanket ban on publishing treatment result photos. What is prohibited is broader: creating a false impression of the results that can be achieved, and misleading users about how a device performs (Article 7 of MDR 2017/745).
Four practical consequences:
- The rules bind the clinic, not only the manufacturer. They apply to advertising a business that uses a medical device to deliver services, which covers hyaluronic acid treatments, lasers and injectable techniques.
- Never pair a result photo with a device brand name. "Result after treatment with laser X" is an advertisement for a specific device, not information about a service.
- Professional-only devices are off limits in ads aimed at the general public. In a 4 September 2025 communication the regulator restated that injectable dermal fillers are intended for people holding a medical profession. Cosmetologists and beauticians do not fall inside that definition.
- Barter counts as advertising. A user opinion published to the general public in exchange for any benefit, including a free treatment, falls under the same rules and requires written approval of the content by the economic operator.
What a mistake costs
The penalty regime is tiered, a detail routinely lost in trade summaries.
Non-financial sanctions sit on top: an order to stop running the ad immediately, and an order to publish the decision in the same media that carried the ad, at the advertiser's expense. For a clinic trading on trust, the second one usually hurts more than the first.
There is also a record-keeping duty: advertising samples together with details of where they ran must be kept for 2 years from the end of the calendar year in which they were published.
The warning: 10 percent and 15 percent
If an ad concerns a medical device, it must carry the statutory formula identifying the product as a medical device to be used according to its instructions for use or label. The regulation sets the minimum area the warning must occupy.
In audiovisual ads, which includes Reels and Facebook video, the warning must also be read aloud clearly. On a 9:16 vertical creative that is a real block of screen space, one you plan at storyboard stage rather than bolt on after the edit.
Why the stakes keep rising
Demand is real and measurable, so the temptation to push creative harder rises with it. Botulinum toxin remains the most common non-surgical procedure performed by plastic surgeons worldwide, though year-on-year momentum swings.
The surrounding market is growing too. Poland's cosmetics market passed PLN 35 billion, up close to 6 percent year on year. More money in the category means more advertising, and more advertising raises the odds of scrutiny.
A six-step creative audit
Run this list before anything reaches Ads Manager. Any "no" stops publication.
- Brand name. Does a device brand name appear in the frame, in a text overlay, in the primary text or in the ad set name? If so, remove it, or build a full device advertisement with the warning and manufacturer details.
- Credentials. Is the procedure shown performed with a device intended for medical professionals, while the person on camera is not one? If so, do not publish.
- Promise. Does the creative imply a guaranteed result, a specific number or a specific timeframe? Replace it with a description of the process.
- Qualifier. Do the creative and the primary text visibly state that results are individual and depend on many factors?
- Targeting. Is the ad set age floor at 18? Without it the creative fails Gate A alone.
- Archive. Are the creative, copy, date and placement logged in a register kept for 2 years?
Steps 1 to 4 are content, step 5 is campaign setup, step 6 is process. In practice step 6 is the one that fails, because nobody owns the archive.
What to publish instead of a transformation
A ladder from safest to riskiest format:
- Process. Preparation, consultation, discussion of contraindications. No promises, high credibility.
- Education. Material explaining how a treatment works and where its limits are, without urging a specific procedure and without brand names.
- Credentials and service scope. Team, hours, price list. A price list on its own is not device advertising.
- Result as informational material. A post-treatment photo carrying an explicit note that outcomes are individual, without a device name and without framing it as a promise met.
The fourth format is permissible but demands discipline: it is information, not a sales promise.
FAQ
Can I show a patient transformation now that Meta allows it?
Meta's approval only governs whether the ad runs on the platform. It does not shield you from liability under medical device law if the image implies a guaranteed result or is tied to a device name. Publish the result as informational material with a clear individual-results qualifier.
Is the patient's consent enough?
Consent resolves image rights and personal data. It does not resolve device advertising rules. These are two independent legal regimes and you need both.
Do organic Instagram posts fall under the rules?
Yes, if they meet the definition of advertising. The law is not limited to paid formats, and opinions from people receiving a benefit, barter included, are covered explicitly.
Is a price list an advertisement?
A price list with treatment names is information about the scope of services. Risk appears when a device brand name or a promised outcome sits next to a line item.
Who is liable if an influencer published the ad?
The economic operator running or having approved the advertising in writing carries responsibility for compliance. Missing written approval does not shift risk onto the influencer, it enlarges it.
Closing
Compliance is not a one-off task. It is a creative register, a repeatable pre-publication checklist and an archive you can open two years later. At Palyri we treat it like any other clinic operating process: written down, assigned to a person, and reconstructable when somebody asks.
Sources
- Meta Transparency Center, Health and Wellness advertising standards, 2026
- Office for Registration of Medicinal Products, Medical Devices and Biocidal Products, Medical device advertising, 2026
- ISAP, Medical Devices Act of 7 April 2022, 2022
- ISAP, Minister of Health regulation of 21 April 2023 on medical device advertising, 2023
- Zurawska Piotrowski Law Firm, Advertising of medical devices and aesthetic medicine, 2026
- ISAPS, Global Survey on Aesthetic/Cosmetic Procedures 2024, 2025
- PMR Market Experts via Wiadomosci Kosmetyczne, Poland beauty market value, 2025
Want to implement this in your clinic?
Book a free Palyri demo. We'll show how it works on your clinic's data.
Book demo via WhatsAppPaulina Zielińska
Konsultant w branży beauty
Ponad 4 lata doświadczenia w branży beauty: najpierw od środka jako manager kliniki, teraz jako niezależny konsultant. Wdrożyła systemy automatyzacji sprzedaży i CRM w kilkudziesięciu klinikach estetycznych w Polsce.